Seeking Alpha
Value, growth, long-term horizon, medium-term horizon
Profile| Send Message|
( followers)  

Do you like to follow the buying trends of company insiders or sell side analysts? We ran a screen on stocks seeing positive attention from both groups.

We began by screening for stocks with significant net insider purchases over the last six months, indicating that insiders at these companies believe their employers will outperform. We then screened for those with current 'Buy' ratings from Canaccord Genuity, also indicating that sell side analysts at Canaccord believe these stocks will outperform.

Interactive Chart: Press Play to compare changes in analyst ratings over the last two years for six stocks mentioned below. Analyst ratings sourced from Zacks Investment Research.‬

We also created a price-weighted index of the stocks mentioned below, and monitored the performance of the list relative to the S&P 500 index over the last month. To access a complete analysis of this list's recent performance, click here.

Do you think these stocks will outperform like they expect? Use this list as a starting point for your own analysis.

1. AngioDynamics Inc. (NASDAQ:ANGO): Designs, develops, manufactures, and markets various therapeutic and diagnostic devices that enable interventional physicians to treat PVD, tumors, and other non-coronary diseases. On 7/15/11, Canaccord Genuity had a Buy rating on the stock. Over the last six months, insiders were net buyers of 8,500 shares, which represents about 0.04% of the company's 22.67M share float.

2. Badger Meter Inc. (NYSE:BMI): Engages in manufacturing and marketing liquid flow measurement and control technology products worldwide. On 4/20/11, Canaccord Genuity had a Buy rating on the stock. Over the last six months, insiders were net buyers of 7,693 shares, which represents about 0.05% of the company's 14.35M share float.

3. Carbonite, Inc. (NASDAQ:CARB): Provides online backup solutions for consumers and small and medium sized businesses. On 9/20/11, Canaccord Genuity had a Buy rating on the stock. Over the last six months, insiders were net buyers of 2,066,920 shares, which represents about 22.59% of the company's 9.15M share float.

4. Chesapeake Energy Corporation (NYSE:CHK): Engages in the acquisition, development, exploration, and production of natural gas and oil properties in the United States. On 2/24/11, Canaccord Genuity had a Buy rating on the stock. Over the last six months, insiders were net buyers of 207,300 shares, which represents about 0.03% of the company's 630.28M share float.

5. Synta Pharmaceuticals Corp. (NASDAQ:SNTA): Focuses on the discovery, development, and commercialization of small molecule drug candidates for treating severe medical conditions, including cancer and chronic inflammatory diseases. On 2/28/11, Canaccord Genuity had a Buy rating on the stock. Over the last six months, insiders were net buyers of 507,059 shares, which represents about 1.77% of the company's 28.65M share float.

6. TranS1, Inc. (TSON): Focuses on the design, development, and marketing of products that implement its proprietary surgical approach to treat degenerative disc disease and instability affecting the lower lumbar region of the spine. On 8/2/11, Canaccord Genuity had a Buy rating on the stock. Over the last six months, insiders were net buyers of 2,716,880 shares, which represents about 18.03% of the company's 15.07M share float.

*Insider data sourced from Yahoo! Finance, all other data sourced from Finviz.

Source: 6 Insider Stock Picks Rated Buy By Canaccord Genuity